Roche has said it plans to UK price its latest ... based on a price of £1,470 for 28 capsules. Although Novartis also offered a commercially confidential discount for Gilenya in order to get ...

From glow-boosting face masks to ultra-hydrating body oils, these skincare picks deliver serious results — without breaking ...

Lonza Group AG has selected Bank of America Corp. and Centerview Partners to arrange the sale of its capsules and health ingredients business, according to people familiar with the matter, as part of ...

Roche (RHHBY) unveiled its proprietary, breakthrough sequencing by expansion technology, establishing a new category of next-generation ...

Announcing a new publication for Acta Materia Medica journal. Icaritin (ICA) is a prenylflavonoid natural product extracted from plants of the Epimedium genus.

In a report released today, Florent Cespedes from Bernstein maintained a Buy rating on Roche Holding AG (RHHVF – Research Report), with a price ...

The FDA on Wednesday approved the industry’s first-ever tablet treatment for spinal muscular atrophy— Roche ’s SMN2 splicing ...

Roche has announced that a tablet formulation of its spinal muscular atrophy (SMA) treatment Evrysdi (risdiplam) has been approved by the US Food and Drug Administration (FDA). Evrysdi was originally ...

Roche, announced that the US Food and Drug Administration (FDA) has approved a New Drug Application (NDA) for an Evrysdi (risdiplam) tablet for people living with spinal muscular atrophy (SMA).

If you've just unboxed a new Android tablet, whether it's the latest Samsung Galaxy Tab S10 Ultra or the Google Pixel Tablet, chances are you're not getting the best experience out of the box.

Tablets are, effectively, computers. We benchmark tablets against common performance and graphics metrics and run battery life tests for video playback. But we also look at what tablets can do ...